Retatrutide appears to be a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By stimulating these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secretion, and ultimat